Well said J.W and also potential for Merck to move into Phase 2 for BNC375 early 2019 which will trigger a large milestone payment ($20 to $30 m).
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025